Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 36, 1023-1025, March 1, 1976]
© 1976 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Duuren, B. L.
Right arrow Articles by Segal, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Duuren, B. L.
Right arrow Articles by Segal, A.

Inhibition of Two-Stage Carcinogenesis in Mouse Skin with Bis(2-chloroethyl)sulfide1

Benjamin L. Van Duuren and Alvin Segal

Laboratory of Organic Chemistry and Carcinogenesis, Institute of Environmental Medicine, New York University Medical Center, New York, New York 10016

ICR/Ha Swiss mice, 30 females/group, were given a single application of 20 µg 7,12-dimethylbenz(a)anthracene, followed 2 weeks later by three times weekly applications of phorbol myristate acetate (PMA), 2.5 µg/application. In the accompanying inhibition experiments, sulfur mustard [SM;bis(2-chloroethyl)sulfide] was applied at a dose of 20 µg/application during the promotion phase, either on the same day as PMA, i.e., three times weekly, or on alternate days, i.e., twice weekly. The experiments were continued for 385 days. The control group, i.e., without SM, resulted in 27 of 30 mice with a total of 281 papillomas. Sixteen of these mice also bore squamous cell carcinomas. In the two groups also receiving SM, two or three times weekly, 2 of 30 and 1 of 30 mice, respectively, bore papillomas. Carcinomas were not observed in these groups. The inflammatory response of mouse skin to the combined treatments of SM and PMA was no greater than with PMA alone.

1 This work was supported by USPHS Grants CA 15095, ES 00260, and CA 13343.

Received 10/ 9/75. Accepted 11/24/75.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1976 by the American Association for Cancer Research.